共 86 条
- [1] Woodward DF(2011)International union of basic and clinical pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress Pharmacol Rev. 63 471-538
- [2] Jones RL(2004)Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacol Ther 103 147-166
- [3] Narumiya S(1995)Molecular cloning and characterization of the human prostanoid DP receptor J Biol Chem 270 18910-18916
- [4] Hata AN(2013)Role of prostaglandin receptor EP2 in the regression of cancer cell proliferation, invasion, and inflammation J Pharmacol Exp Ther 344 360-367
- [5] Breyer RM(2007)Association between prostaglandin E Prostagland Leukot Essent Fatty Acids 77 15-20
- [6] Boie Y(2007) receptor gene and essential hypertension Genes Immun 8 398-403
- [7] Sawyer N(1994)Association of PTGDR gene polymorphisms with asthma in two Caucasian populations Mol Pharmacol 46 213-220
- [8] Slipetz DM(2015)Cloning of a novel human prostaglandin receptor with characteristics of pharmacologically defined EP2 subtype FEBS Lett 589 766-772
- [9] Metters KM(2008)Human EP2 prostanoid receptors exhibit more constraints to mutations than human DP prostanoid receptors EMBO J 27 384-393
- [10] Abramovitz M(2018)Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4 FEBS J 283 3931-3940